[O-097] Introduction of Lenvatinib for intermediate stage HCC with dismal prognosis after TACE
Abstract password authentication.
Please see the page 10 of the JSIR 2020 Program & Abstract for log-in password.
Scientific Session
TACE
Wed. Aug 26, 2020 10:24 AM - 11:48 AM Room 4 (Kairaku C)
座長:喜多 竜一(大阪赤十字病院 消化器内科), 関 明彦(吹田徳洲会病院 腫瘍内科)
Abstract password authentication.
Please see the page 10 of the JSIR 2020 Program & Abstract for log-in password.